biotech / news / / Reuters
BioNTech said in March its two co-founders and leading executives will leave by the end of the year to start a new venture.
BioNTech will exit operations in Idar-Oberstein, Marburg, and Tuebingen by the end of 2027.
KEY POINTS
- Singapore operations will end in the first quarter of 2027, according to the company statement.
- BioNTech plans to achieve up to 500 million euros in annual cost savings by 2029.
- The company will repurchase up to $1 billion of its own shares over the next 12 months.
- BioNTech reported a first-quarter net loss of 532 million euros this year.
COMPANIES
Summarized by Newsio from Reuters. How we summarize →